文献速递心外重症与机械循环支持瓣膜外科

心室辅助装置诱导血清天然IgG抗体并与心脏移植后原发性移植物功能障碍相关

Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.
PubMed 文献 · J Heart Lung Transplant · 2017-03-24

该研究检测了206例心脏移植受者移植前血清中的天然抗体,其中128例曾植入VAD,78例未植入。结果显示VAD患者血清IgG天然抗体水平显著升高,且升高的移植前IgG天然抗体与原发性移植物功能障碍(PGD)的发生相关,提示VAD可能通过非特异性B细胞活化诱导IgG致敏并参与PGD炎症反应。

要点

  • VAD植入后心脏移植受者移植前血清IgG天然抗体水平显著升高。
  • 移植前升高的IgG天然抗体与心脏移植后PGD发生相关。
  • VAD与未VAD患者间血清IgM天然抗体水平无差异。

核心结论

  • VAD支持可诱导针对凋亡细胞和氧化表位的IgG天然抗体,支持VAD引起广泛非特异性B细胞活化导致IgG致敏。
  • 血清IgG天然抗体水平与PGD发生相关,提示这些抗体可能参与PGD伴随的炎症反应。

研究设计与样本

  • 研究纳入206例原位心脏移植受者移植前血清样本,其中VAD患者128例,无VAD患者78例。
  • 采用流式细胞术检测血清对凋亡细胞的反应性,采用酶联免疫吸附试验检测对丙二醛氧化表位的反应性,以评估IgM和IgG天然抗体。

主要发现

  • VAD患者与无VAD患者血清IgM天然抗体水平无差异。
  • VAD患者血清IgG天然抗体水平较无VAD患者显著升高。
  • VAD患者植入前血清IgG天然抗体水平较低,提示IgG天然抗体升高可能归因于VAD的存在。
  • 移植前升高的IgG天然抗体水平与原发性移植物功能障碍(PGD)的发生相关。

临床怎么用

  • 心脏移植术前评估可关注VAD植入史及移植前血清IgG天然抗体水平,以识别PGD高风险受者。
  • VAD植入后需考虑非HLA致敏可能,IgG天然抗体或可作为免疫监测的补充指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pre-transplant sensitization is a limiting factor in solid-organ transplantation. In heart transplants, ventricular assist device (VAD) implantation has been associated with sensitization to human leukocyte antigens (HLA). The effect of VAD on non-HLA antibodies is unclear. We have previously shown that polyreactive natural antibodies (Nabs) contribute to pre-sensitization in kidney allograft recipients. Here we assessed generation of Nabs after VAD implantation in pre-transplant sera and examined their contribution to cardiac allograft outcome. METHODS: IgM and IgG Nabs were tested in pre-transplant serum samples collected from 206 orthotopic heart transplant recipients, including 128 patients with VAD (VAD patients) and 78 patients without VAD (no-VAD patients). Nabs were assessed by testing serum reactivity to apoptotic cells by flow cytometry and to the generic oxidized epitope, malondialdehyde, by enzyme-linked immunosorbent assay. RESULTS: No difference was observed in serum levels of IgM Nabs between VAD and no-VAD patients. However, serum IgG Nabs levels were significantly increased in VAD compared with no-VAD patients. This increase was likely due to the presence of the VAD, as revealed by lower serum IgG Nabs levels before implantation. Elevated pre-transplant IgG Nabs level was associated with development of primary graft dysfunction (PGD). CONCLUSIONS: Our study demonstrates that VAD support elicits IgG Nabs reactive to apoptotic cells and oxidized epitopes. These findings further support broad and non-specific B-cell activation by VAD, resulting in IgG sensitization. Moreover, the association of serum IgG Nabs levels with development of PGD suggests a possible role for these antibodies in the inflammatory reaction accompanying this complication.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. See SB, Clerkin KJ, Kennel PJ, et al. Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation. J Heart Lung Transplant. 2017. PMID: 28431981. doi:10.1016/j.healun.2017.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。